JP2021508236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508236A5 JP2021508236A5 JP2020527921A JP2020527921A JP2021508236A5 JP 2021508236 A5 JP2021508236 A5 JP 2021508236A5 JP 2020527921 A JP2020527921 A JP 2020527921A JP 2020527921 A JP2020527921 A JP 2020527921A JP 2021508236 A5 JP2021508236 A5 JP 2021508236A5
- Authority
- JP
- Japan
- Prior art keywords
- human animal
- trkb
- endogenous
- seq
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 claims description 54
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 claims description 54
- 101100517383 Homo sapiens NTRK2 gene Proteins 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 39
- 230000001086 cytosolic effect Effects 0.000 claims description 29
- 108091026890 Coding region Proteins 0.000 claims description 24
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 20
- 230000008685 targeting Effects 0.000 claims description 19
- 101150056950 Ntrk2 gene Proteins 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 9
- 210000004102 animal cell Anatomy 0.000 claims description 7
- 230000000324 neuroprotective effect Effects 0.000 claims description 7
- 102000005937 Tropomyosin Human genes 0.000 claims description 6
- 108010030743 Tropomyosin Proteins 0.000 claims description 6
- 239000000556 agonist Substances 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 6
- 230000003833 cell viability Effects 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 210000003994 retinal ganglion cell Anatomy 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 102000025171 antigen binding proteins Human genes 0.000 claims description 4
- 108091000831 antigen binding proteins Proteins 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 210000001328 optic nerve Anatomy 0.000 claims description 4
- 150000003384 small molecules Chemical group 0.000 claims description 4
- 208000030768 Optic nerve injury Diseases 0.000 claims description 3
- 238000002266 amputation Methods 0.000 claims description 3
- 230000037396 body weight Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 102000043136 MAP kinase family Human genes 0.000 claims description 2
- 108091054455 MAP kinase family Proteins 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 108091007960 PI3Ks Proteins 0.000 claims description 2
- 241000283984 Rodentia Species 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 235000012631 food intake Nutrition 0.000 claims description 2
- 102000006261 human tropomyosin-related kinase-B Human genes 0.000 claims description 2
- 108010058135 human tropomyosin-related kinase-B Proteins 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 230000033001 locomotion Effects 0.000 claims description 2
- 230000037361 pathway Effects 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 108091005682 Receptor kinases Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 102000038030 PI3Ks Human genes 0.000 claims 1
- 108020005004 Guide RNA Proteins 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 101710163270 Nuclease Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 108091033409 CRISPR Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023171306A JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762592905P | 2017-11-30 | 2017-11-30 | |
| US62/592,905 | 2017-11-30 | ||
| US201862661373P | 2018-04-23 | 2018-04-23 | |
| US62/661,373 | 2018-04-23 | ||
| PCT/US2018/063390 WO2019108983A1 (en) | 2017-11-30 | 2018-11-30 | Non-human animals comprising a humanized trkb locus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171306A Division JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508236A JP2021508236A (ja) | 2021-03-04 |
| JP2021508236A5 true JP2021508236A5 (enExample) | 2021-12-16 |
| JP7361031B2 JP7361031B2 (ja) | 2023-10-13 |
Family
ID=64734209
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527921A Active JP7361031B2 (ja) | 2017-11-30 | 2018-11-30 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| JP2023171306A Active JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171306A Active JP7610672B2 (ja) | 2017-11-30 | 2023-10-02 | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11419318B2 (enExample) |
| EP (2) | EP4299732A3 (enExample) |
| JP (2) | JP7361031B2 (enExample) |
| KR (1) | KR102709884B1 (enExample) |
| CN (2) | CN111655031B (enExample) |
| AU (2) | AU2018375796B2 (enExample) |
| CA (1) | CA3076377A1 (enExample) |
| ES (1) | ES2973937T3 (enExample) |
| IL (2) | IL310006A (enExample) |
| SG (1) | SG11202002456WA (enExample) |
| WO (1) | WO2019108983A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7361031B2 (ja) | 2017-11-30 | 2023-10-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| KR20250121150A (ko) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | 치료제를 시험하기 위한 인간화된 설치류 |
| HUE067361T2 (hu) | 2018-07-16 | 2024-10-28 | Regeneron Pharma | Ditra betegség rágcsáló modelljei és alkalmazásaik |
| WO2020179844A1 (ja) * | 2019-03-04 | 2020-09-10 | 公益財団法人東京都医学総合研究所 | Ｔｒｋ断片をコードする核酸構築物、及びその利用 |
| WO2021158883A1 (en) * | 2020-02-07 | 2021-08-12 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized klkb1 locus and methods of use |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| US5877016A (en) * | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
| WO1999005266A2 (en) | 1997-07-26 | 1999-02-04 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
| AU2001273245A1 (en) | 2000-07-05 | 2002-01-14 | Pangene Corporation | Modulators of trk protein activity, compositions and uses |
| US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7060429B2 (en) * | 2001-02-22 | 2006-06-13 | University Of Maryland, Baltimore | Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| AUPR451401A0 (en) | 2001-04-20 | 2001-05-24 | Monash University | A method of nuclear transfer |
| US7612250B2 (en) | 2002-07-29 | 2009-11-03 | Trustees Of Tufts College | Nuclear transfer embryo formation method |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| EP1802193B1 (en) | 2004-10-19 | 2014-04-30 | Regeneron Pharmaceuticals, Inc. | Method for generating a mouse homozygous for a genetic modification |
| CN101117633B (zh) | 2006-08-03 | 2011-07-20 | 上海交通大学附属儿童医院 | 一种细胞核移植方法 |
| CN101157730A (zh) | 2006-09-25 | 2008-04-09 | 南方医科大学珠江医院 | 一种携带神经营养因子穿过血脑屏障的融合蛋白及其编码基因与用途 |
| JP2011501760A (ja) | 2007-10-23 | 2011-01-13 | ノバルティス アーゲー | 呼吸器疾患の処置のためのｔｒｋｂ抗体の使用 |
| KR20100120226A (ko) | 2008-04-11 | 2010-11-12 | 유티씨 파워 코포레이션 | 매니폴드 섬프를 갖는 바이폴라 플레이트 및 연료 전지 |
| MX368932B (es) | 2009-06-26 | 2019-10-22 | Regeneron Pharma | Anticuerpos biespecificos facilmente aislados con formato de inmunoglobulina original. |
| RU2425880C2 (ru) | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| US8518392B2 (en) | 2009-08-14 | 2013-08-27 | Regeneron Pharmaceuticals, Inc. | Promoter-regulated differentiation-dependent self-deleting cassette |
| TR201903376T4 (tr) | 2009-10-29 | 2019-04-22 | Regeneron Pharma | Çok fonksiyonlu alleller. |
| SG10201510056SA (en) | 2011-10-28 | 2016-01-28 | Regeneron Pharma | Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| RU2751240C2 (ru) | 2011-10-28 | 2021-07-12 | Регенерон Фармасьютикалс, Инк. | Гуманизированные il-6 и рецептор il-6 |
| KR102295746B1 (ko) | 2011-10-28 | 2021-09-01 | 리제너론 파아마슈티컬스, 인크. | 유전자 변형된 주요 조직적합성 복합체 마우스 |
| JP6275120B2 (ja) | 2012-04-25 | 2018-02-07 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 大きい標的化ベクターによるヌクレアーゼ媒介標的化 |
| FI3597749T3 (fi) | 2012-05-25 | 2023-10-09 | Univ California | Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten |
| WO2014033644A2 (en) | 2012-08-28 | 2014-03-06 | Novartis Ag | Methods of nuclease-based genetic engineering |
| ES2748662T3 (es) | 2012-11-05 | 2020-03-17 | Institute For Res In Biomedicine Irb | Roedores inmunodeficientes modificados genéticamente y métodos de uso de los mismos |
| PT3363902T (pt) | 2012-12-06 | 2019-12-19 | Sigma Aldrich Co Llc | Modificação e regulação de genoma baseadas em crispr |
| JP6475172B2 (ja) | 2013-02-20 | 2019-02-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ラットの遺伝子組換え |
| CA2900832A1 (en) | 2013-02-20 | 2014-08-28 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized t-cell co-receptors |
| US20150342163A1 (en) | 2013-02-22 | 2015-12-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex mice |
| JP6444321B2 (ja) | 2013-02-22 | 2018-12-26 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヒト化主要組織適合性遺伝子複合体を発現するマウス |
| EP3456831B1 (en) | 2013-04-16 | 2021-07-14 | Regeneron Pharmaceuticals, Inc. | Targeted modification of rat genome |
| SMT202500280T1 (it) | 2013-09-23 | 2025-09-12 | Regeneron Pharma | Animali non umani aventi un gene umanizzato della proteina regolatrice del segnale |
| EP3071024B1 (en) | 2013-11-19 | 2018-09-05 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized b-cell activating factor gene |
| EP3430898A1 (en) | 2013-11-19 | 2019-01-23 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized a proliferation-inducing ligand gene |
| MX388127B (es) * | 2013-12-11 | 2025-03-19 | Regeneron Pharma | Metodos y composiciones para la modificacion dirigida de un genoma. |
| US10370692B2 (en) | 2013-12-20 | 2019-08-06 | Hoffmann-La Roche Inc. | Recombinant polypeptide production methods |
| HK1231374A1 (zh) * | 2014-02-21 | 2017-12-22 | Regeneron Pharmaceuticals, Inc. | 用於靶抗原的细胞特异性调变的方法、组合物和试剂盒 |
| SMT202000332T1 (it) | 2014-04-08 | 2020-07-08 | Regeneron Pharma | Animali non umani aventi recettori fc-gamma umanizzati |
| NO2785538T3 (enExample) | 2014-05-07 | 2018-08-04 | ||
| EP3143043B1 (en) * | 2014-05-16 | 2022-12-14 | Pfizer Inc. | Bispecific antibodies with engineered ch1-cl interfaces |
| KR102821645B1 (ko) | 2014-05-19 | 2025-06-19 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| DK3157956T3 (da) | 2014-06-19 | 2020-04-27 | Regeneron Pharma | Ikke-humane dyr med et humaniseret gen med programmeret celledød 1 |
| MX384887B (es) | 2014-06-23 | 2025-03-14 | Regeneron Pharma | Ensamblaje de adn mediado por nucleasa. |
| SG10201911411YA (en) | 2014-06-26 | 2020-02-27 | Regeneron Pharma | Methods and compositions for targeted genetic modifications and methods of use |
| WO2016010840A1 (en) | 2014-07-16 | 2016-01-21 | Novartis Ag | Method of encapsulating a nucleic acid in a lipid nanoparticle host |
| KR20170083534A (ko) * | 2014-09-19 | 2017-07-18 | 리제너론 파마슈티칼스 인코포레이티드 | 키메라 항원 수용체 |
| CA3176380A1 (en) | 2014-11-21 | 2016-05-26 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for targeted genetic modification using paired guide rnas |
| BR112017010793A2 (pt) | 2014-11-24 | 2017-12-26 | Regeneron Pharma | animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo. |
| ES2969389T3 (es) * | 2014-12-05 | 2024-05-17 | Regeneron Pharma | Animales no humanos que tienen un gen del grupo de diferenciación 47 humanizado |
| EP4399969A3 (en) | 2014-12-09 | 2024-10-30 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized cluster of differentiation 274 gene |
| AU2016246698B2 (en) | 2015-04-06 | 2022-06-02 | Regeneron Pharmaceuticals, Inc. | Humanized T cell mediated immune responses in non-human animals |
| PT3376857T (pt) * | 2015-11-20 | 2021-05-27 | Regeneron Pharma | Animais não humanos com um gene humanizado 3 de ativação de linfócitos |
| MX2020003550A (es) * | 2017-11-30 | 2020-08-03 | Regeneron Pharma | Anticuerpos monoclonales anti-trkb y metodos de uso. |
| JP7361031B2 (ja) | 2017-11-30 | 2023-10-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| KR20250121150A (ko) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | 치료제를 시험하기 위한 인간화된 설치류 |
| HUE067361T2 (hu) | 2018-07-16 | 2024-10-28 | Regeneron Pharma | Ditra betegség rágcsáló modelljei és alkalmazásaik |
-
2018
- 2018-11-30 JP JP2020527921A patent/JP7361031B2/ja active Active
- 2018-11-30 US US16/206,330 patent/US11419318B2/en active Active
- 2018-11-30 CN CN201880087972.5A patent/CN111655031B/zh active Active
- 2018-11-30 IL IL310006A patent/IL310006A/en unknown
- 2018-11-30 AU AU2018375796A patent/AU2018375796B2/en active Active
- 2018-11-30 EP EP23207807.1A patent/EP4299732A3/en active Pending
- 2018-11-30 ES ES18821882T patent/ES2973937T3/es active Active
- 2018-11-30 EP EP18821882.0A patent/EP3585164B1/en active Active
- 2018-11-30 KR KR1020207013978A patent/KR102709884B1/ko active Active
- 2018-11-30 CA CA3076377A patent/CA3076377A1/en active Pending
- 2018-11-30 CN CN202211340155.0A patent/CN116064611A/zh active Pending
- 2018-11-30 SG SG11202002456WA patent/SG11202002456WA/en unknown
- 2018-11-30 WO PCT/US2018/063390 patent/WO2019108983A1/en not_active Ceased
- 2018-11-30 IL IL274740A patent/IL274740B2/en unknown
-
2022
- 2022-06-30 US US17/810,029 patent/US12396444B2/en active Active
-
2023
- 2023-10-02 JP JP2023171306A patent/JP7610672B2/ja active Active
-
2025
- 2025-02-07 AU AU2025200858A patent/AU2025200858A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508236A5 (enExample) | ||
| JP2019216750A (ja) | ヒト化ｉｌ−１５動物 | |
| JP6192865B2 (ja) | ｌｉｎｃＲＮＡ欠失非ヒト動物 | |
| JP2019047818A (ja) | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 | |
| JP2021505187A (ja) | 遺伝子編集のためのｃｐｆ１関連方法及び組成物 | |
| CA3179113A1 (en) | Selection and monitoring methods for xenotransplantation | |
| CN111549072B (zh) | Vista基因人源化动物细胞及动物模型的构建方法与应用 | |
| IL274740B2 (en) | Non-human animals comprising a humanized trkb locus | |
| CN112725379B (zh) | 人源化cd40基因改造动物模型的构建方法及应用 | |
| IL319209A (en) | Non-human animals containing a humanized ASGR1 locus | |
| Kalds et al. | When less is more: targeting the myostatin gene in livestock for augmenting meat production | |
| EP2135951A1 (en) | Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins | |
| NZ336813A (en) | Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B) DNA and uses in the promotion of growth of new blood vessels | |
| CN108024522A (zh) | Etv2及其用途 | |
| JP2018522553A5 (enExample) | ||
| US20230172170A1 (en) | Non-human animals having a humanized cxcl13 gene | |
| JP2018523999A5 (enExample) | ||
| CN111019972A (zh) | 一种cd27人源化小鼠模型的构建方法及其应用 | |
| CN117210497A (zh) | Abcg4基因在构建脑动脉粥样硬化伴肺部增大小鼠模型中的应用 | |
| WO2013056664A1 (zh) | 家蚕丝素重链基因突变序列及突变的方法和应用 | |
| JP2024539928A (ja) | 改変ｃａｃｎｇ１遺伝子座を含む非ヒト動物 | |
| Hu et al. | A perspective on fish gonad manipulation for biotechnical applications | |
| JP2018520682A5 (enExample) | ||
| CN116058335B (zh) | 一种自发强直性脊柱炎模型的构建方法和应用 | |
| US9999206B2 (en) | Model and method for a transgenic bovidae expressing cardiac fibrosis and associated pathology |